US 8147833
Prevention and treatment of synucleinopathic and amyloidogenic disease
granted A61KA61K2039/505A61K2039/55566
Quick answer
US patent 8147833 (Prevention and treatment of synucleinopathic and amyloidogenic disease) held by The Regents of the University of California expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61K2039/55566, A61K2039/575, A61K39/0007